These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. [20 cases of acute encephalopathy with myoclonus during treatments with orally-administered bismuth salts]. Buge A, Rancurel G, Poisson M, Gazengel J, Dechy H, Fressinaud L, Emile J. Ann Med Interne (Paris); 1974 Dec; 125(12):877-88. PubMed ID: 4469951 [No Abstract] [Full Text] [Related]
3. [Polygraphic study of bismuth-induced myoclonic encephalopathy]. Gastaut JL, Tassinari CA, Terzano G, Picornell I. Rev Electroencephalogr Neurophysiol Clin; 1975 Dec; 5(3):295-302. PubMed ID: 1230925 [No Abstract] [Full Text] [Related]
4. [Clinical and electroencephalographic correlates in bismuth-induced myoclonic encephalopathy]. Gastaut JL, Jouglard J. Therapie; 1980 Dec; 35(3):293-6. PubMed ID: 7423414 [No Abstract] [Full Text] [Related]
5. Chronic encephalopathy with ataxia, myoclonus, and auditory neuropathy: A case of bismuth poisoning. Siram R, Botta R, Kashikunte C, Pal PK, Yadav R. Neurol India; 2017 Dec; 65(1):186-187. PubMed ID: 28084272 [No Abstract] [Full Text] [Related]
7. [Clinical and electroencephalographic aspects of encephalopathy caused by insoluble bismuth salts. Apropos of 9 cases]. Mabin D, Bedou G, Tuset MC. Sem Hop Ther; 1976 Feb; 52(2):109-16. PubMed ID: 982067 [No Abstract] [Full Text] [Related]
8. [The relationship between the course of bismuth encephalopathy and the amount of bismuth in blood and urine]. Boiteau HL, Cler JM, Mathé JF, Delobel R, Fève J. Eur J Toxicol Environ Hyg; 1976 Feb; 9(4):233-9. PubMed ID: 976332 [Abstract] [Full Text] [Related]
9. [Bismuth myoclonic encephalopathies. Their course and lasting or definitive late complications]. Buge A, Rancurel G, Dechy H. Rev Neurol (Paris); 1977 Feb; 133(6-7):401-15. PubMed ID: 929035 [Abstract] [Full Text] [Related]
10. [Reversible encephalopathies caused by bismuth salts. 5 further cases]. Lhermitte F, Degos CF, Signoret JL. Nouv Presse Med; 1975 Feb 08; 4(6):419-20. PubMed ID: 1129094 [Abstract] [Full Text] [Related]
11. Bismuth absorption and myoclonic encephalopathy during bismuth subsalicylate therapy. Mendelowitz PC, Hoffman RS, Weber S. Ann Intern Med; 1990 Jan 15; 112(2):140-1. PubMed ID: 2294817 [No Abstract] [Full Text] [Related]
12. [Myoclonic encephalopathy caused by bismuth salts. Efficacy of treatment with dimercaprol]. Molina JA, Calandre L, Bermejo F, Posadas F, Fernández-Ortega JD. Med Clin (Barc); 1989 Jun 03; 93(1):20-2. PubMed ID: 2770373 [Abstract] [Full Text] [Related]
18. [Myoclonic encephalopathy due to ingestion of insoluble salts of bismuth]. Cambier J, Dairou R. Arch Fr Mal App Dig; 1975 Feb 03; 64(1):5-9. PubMed ID: 1164144 [No Abstract] [Full Text] [Related]
19. [The bismuth-encephalopathy - a new pathological syndrome (author's transl)]. Eichler I. Wien Klin Wochenschr; 1979 Apr 27; 91(9):314-20. PubMed ID: 109997 [Abstract] [Full Text] [Related]